---
title: "BIOCAUSE HEILEN PHARMA: Hydrochloride of Methoxychlorpromazine has received approval for the listing application of chemical raw materials"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/257492265.md"
description: "According to the Zhitong Finance APP, BIOCAUSE HEILEN PHARMA announced that the company recently received the \"Approval Notice for the Market Application of Chemical Raw Materials\" issued by the National Medical Products Administration for Metoclopramide Hydrochloride. Metoclopramide Hydrochloride is a dopamine receptor antagonist primarily used to relieve symptoms of nausea and vomiting, and it can also promote gastrointestinal motility to improve issues such as dyspepsia and delayed gastric emptying"
datetime: "2025-09-16T08:01:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/257492265.md)
  - [en](https://longbridge.com/en/news/257492265.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/257492265.md)
---

# BIOCAUSE HEILEN PHARMA: Hydrochloride of Methoxychlorpromazine has received approval for the listing application of chemical raw materials

According to the Zhitong Finance APP, BIOCAUSE HEILEN PHARMA (301211.SZ) announced that the company recently received the "Approval Notice for the Market Application of Chemical Raw Materials" for Metoclopramide Hydrochloride issued by the National Medical Products Administration. Metoclopramide Hydrochloride is a dopamine receptor antagonist primarily used to relieve symptoms of nausea and vomiting, and it can also promote gastrointestinal motility to improve issues such as dyspepsia and delayed gastric emptying

### Related Stocks

- [301211.CN](https://longbridge.com/en/quote/301211.CN.md)

## Related News & Research

- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)
- [Aquarius crosses 10% stake in Carvolix, holds 11.65% of shares](https://longbridge.com/en/news/296112439.md)
- [REG - Nomura Intl. PLC Spire Healthcare Grp - Form 8.3 - SPIRE HEALTHCARE GROUP PLC](https://longbridge.com/en/news/296096467.md)
- [Max Power to present Lawson natural hydrogen discovery at IMAGE ’26 in Houston](https://longbridge.com/en/news/296226273.md)
- [13:22 ET/C O R R E C T I O N -- Rayence/](https://longbridge.com/en/news/296256530.md)